Jamie Woods
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,174 and has fallen 98.7% since, to $16 in 2024.
Across 122 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$265
- AstraZeneca$181
- Lilly USA, LLC$180
- Novo Nordisk$158
- GSK$152
- AbbVie$140
- plus $838 from 18 others
What the payments were for
- Food & beverage$1,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 18 | $265 |
| AstraZeneca | 11 | $181 |
| Lilly USA, LLC | 11 | $180 |
| Novo Nordisk | 9 | $158 |
| GSK | 10 | $152 |
| AbbVie | 9 | $140 |
| Sunovion Pharmaceuticals Inc. | 7 | $105 |
| Pfizer | 5 | $80 |
| Boehringer Ingelheim | 5 | $80 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Abbott | 4 | $56 |
| Merck | 3 | $50 |
| Astellas Pharma US Inc | 2 | $50 |
| Shield Therapeutics Inc | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $47 |
| Nestle Healthcare Nutrition Inc. | 3 | $46 |
| Sumitomo Pharma America, Inc. | 4 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Exact Sciences | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Johnson & Johnson | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $13 |
| Athena Bioscience, LLC | 1 | $13 |
How this compares
$1,914 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 14 | $316 |
| Glycopyrrolate | 13 | $205 |
| Metformin Hcl | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other family in Erie
- Ashley SonneyErie$26K
- Alyssa MeighanErie$15K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.